Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-11

Clinical Trial Update: Acamprosate Initiated During Alcohol Detoxification [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating acamprosate initiated during alcohol detoxification for alcohol use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Campral (acamprosate)

Snippet

Sponsor: Forest Laboratories | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED